Perseus Proteomics Inc.
Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.
Filings
Financials
Ownership
Governance
Capital Returns
Assets
Latest values as text and table
Perseus Proteomics Inc.
Perseus Proteomics Inc. (株式会社ペルセウスプロテオミクス, 4882), Pharmaceutical. A board of 8 and 10 largest shareholders, as filed on EDINET for the year to March 2026. EDINET filing S100YNJJ, filed 2026-06-30. Source: company filings on EDINET (Financial Services Agency of Japan).
Financial summary
| Fiscal year end | Revenue (¥bn) | Profit (¥bn) | Total assets (¥bn) | EPS (¥) | DPS (¥) | Employees |
|---|---|---|---|---|---|---|
| 2022-03-31 | 0.1 | −0.6 | 3.3 | −54.47 | — | 21 |
| 2023-03-31 | 0.1 | −0.8 | 2.6 | −66.93 | — | 24 |
| 2024-03-31 | 0.1 | −1.1 | 1.7 | −93.69 | — | 25 |
| 2025-03-31 | 0.1 | −0.9 | 1.8 | −63.41 | — | 32 |
| 2026-03-31 | 0.1 | −0.7 | 1.6 | −48.17 | — | 35 |
Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown